InvestorsHub Logo
Followers 61
Posts 11632
Boards Moderated 0
Alias Born 01/04/2015

Re: groton68 post# 237879

Monday, 08/20/2018 4:47:26 PM

Monday, August 20, 2018 4:47:26 PM

Post# of 403222
Nope. Read the damn article.

“GC4419 has completed phase 1 and 2 trials and is poised to enter phase 3 this year. If approved, it could be used to ward off SOM and its side effects not just in patients with head and neck cancers, but in those with other types of cancer.”

All my comments are Rated As Pro.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News